292 related articles for article (PubMed ID: 19533084)
1. Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk.
Reiling E; van 't Riet E; Groenewoud MJ; Welschen LM; van Hove EC; Nijpels G; Maassen JA; Dekker JM; 't Hart LM
Diabetologia; 2009 Sep; 52(9):1866-70. PubMed ID: 19533084
[TBL] [Abstract][Full Text] [Related]
2. Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.
Tam CH; Ho JS; Wang Y; Lee HM; Lam VK; Germer S; Martin M; So WY; Ma RC; Chan JC; Ng MC
PLoS One; 2010 Jul; 5(7):e11428. PubMed ID: 20628598
[TBL] [Abstract][Full Text] [Related]
3. Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion.
Hu C; Zhang R; Wang C; Yu W; Lu J; Ma X; Wang J; Jiang F; Tang S; Bao Y; Xiang K; Jia W
PLoS One; 2010 Jul; 5(7):e11761. PubMed ID: 20668700
[TBL] [Abstract][Full Text] [Related]
4. Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk.
Wang H; Liu L; Zhao J; Cui G; Chen C; Ding H; Wang DW
PLoS One; 2013; 8(6):e67665. PubMed ID: 23840762
[TBL] [Abstract][Full Text] [Related]
5. Common variants at the GCK, GCKR, G6PC2-ABCB11 and MTNR1B loci are associated with fasting glucose in two Asian populations.
Takeuchi F; Katsuya T; Chakrewarthy S; Yamamoto K; Fujioka A; Serizawa M; Fujisawa T; Nakashima E; Ohnaka K; Ikegami H; Sugiyama T; Nabika T; Kasturiratne A; Yamaguchi S; Kono S; Takayanagi R; Yamori Y; Kobayashi S; Ogihara T; de Silva A; Wickremasinghe R; Kato N
Diabetologia; 2010 Feb; 53(2):299-308. PubMed ID: 19937311
[TBL] [Abstract][Full Text] [Related]
6. Common genetic variation near melatonin receptor MTNR1B contributes to raised plasma glucose and increased risk of type 2 diabetes among Indian Asians and European Caucasians.
Chambers JC; Zhang W; Zabaneh D; Sehmi J; Jain P; McCarthy MI; Froguel P; Ruokonen A; Balding D; Jarvelin MR; Scott J; Elliott P; Kooner JS
Diabetes; 2009 Nov; 58(11):2703-8. PubMed ID: 19651812
[TBL] [Abstract][Full Text] [Related]
7. Interaction effect of genetic polymorphisms in glucokinase (GCK) and glucokinase regulatory protein (GCKR) on metabolic traits in healthy Chinese adults and adolescents.
Tam CH; Ma RC; So WY; Wang Y; Lam VK; Germer S; Martin M; Chan JC; Ng MC
Diabetes; 2009 Mar; 58(3):765-9. PubMed ID: 19073768
[TBL] [Abstract][Full Text] [Related]
8. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk.
Bouatia-Naji N; Bonnefond A; Cavalcanti-Proença C; Sparsø T; Holmkvist J; Marchand M; Delplanque J; Lobbens S; Rocheleau G; Durand E; De Graeve F; Chèvre JC; Borch-Johnsen K; Hartikainen AL; Ruokonen A; Tichet J; Marre M; Weill J; Heude B; Tauber M; Lemaire K; Schuit F; Elliott P; Jørgensen T; Charpentier G; Hadjadj S; Cauchi S; Vaxillaire M; Sladek R; Visvikis-Siest S; Balkau B; Lévy-Marchal C; Pattou F; Meyre D; Blakemore AI; Jarvelin MR; Walley AJ; Hansen T; Dina C; Pedersen O; Froguel P
Nat Genet; 2009 Jan; 41(1):89-94. PubMed ID: 19060909
[TBL] [Abstract][Full Text] [Related]
9. Common genetic determinants of glucose homeostasis in healthy children: the European Youth Heart Study.
Kelliny C; Ekelund U; Andersen LB; Brage S; Loos RJ; Wareham NJ; Langenberg C
Diabetes; 2009 Dec; 58(12):2939-45. PubMed ID: 19741166
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the transferability of 15 European-derived fasting plasma glucose SNPs in Mexican children and adolescents.
Langlois C; Abadi A; Peralta-Romero J; Alyass A; Suarez F; Gomez-Zamudio J; Burguete-Garcia AI; Yazdi FT; Cruz M; Meyre D
Sci Rep; 2016 Oct; 6():36202. PubMed ID: 27782183
[TBL] [Abstract][Full Text] [Related]
11. Genetic variability of GCKR alters lipid profiles in children with monogenic and autoimmune diabetes.
Tracz A; Madzio J; Gnys P; Malachowska B; Borowiec M; Wyka K; Jarosz-Chobot P; Mysliwiec M; Szadkowska A; Mlynarski W; Fendler W;
Exp Clin Endocrinol Diabetes; 2014 Oct; 122(9):503-9. PubMed ID: 24918535
[TBL] [Abstract][Full Text] [Related]
12. Chronological Age Interacts with the Circadian Melatonin Receptor 1B Gene Variation, Determining Fasting Glucose Concentrations in Mediterranean Populations. Additional Analyses on Type-2 Diabetes Risk.
Sorlí JV; Barragán R; Coltell O; Portolés O; Pascual EC; Ortega-Azorín C; González JI; Estruch R; Saiz C; Pérez-Fidalgo A; Ordovas JM; Corella D
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33138317
[TBL] [Abstract][Full Text] [Related]
13. MTNR1B G24E variant associates With BMI and fasting plasma glucose in the general population in studies of 22,142 Europeans.
Andersson EA; Holst B; Sparsø T; Grarup N; Banasik K; Holmkvist J; Jørgensen T; Borch-Johnsen K; Egerod KL; Lauritzen T; Sørensen TI; Bonnefond A; Meyre D; Froguel P; Schwartz TW; Pedersen O; Hansen T
Diabetes; 2010 Jun; 59(6):1539-48. PubMed ID: 20200315
[TBL] [Abstract][Full Text] [Related]
14. Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.
Florez JC; Jablonski KA; McAteer JB; Franks PW; Mason CC; Mather K; Horton E; Goldberg R; Dabelea D; Kahn SE; Arakaki RF; Shuldiner AR; Knowler WC;
PLoS One; 2012; 7(9):e44424. PubMed ID: 22984506
[TBL] [Abstract][Full Text] [Related]
15. Meta-analyses of the association of G6PC2 allele variants with elevated fasting glucose and type 2 diabetes.
Shi Y; Li Y; Wang J; Wang C; Fan J; Zhao J; Yin L; Liu X; Zhang D; Li L
PLoS One; 2017; 12(7):e0181232. PubMed ID: 28704540
[TBL] [Abstract][Full Text] [Related]
16. A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals.
Rönn T; Wen J; Yang Z; Lu B; Du Y; Groop L; Hu R; Ling C
Diabetologia; 2009 May; 52(5):830-3. PubMed ID: 19241057
[TBL] [Abstract][Full Text] [Related]
17. Variants in MTNR1B influence fasting glucose levels.
Prokopenko I; Langenberg C; Florez JC; Saxena R; Soranzo N; Thorleifsson G; Loos RJ; Manning AK; Jackson AU; Aulchenko Y; Potter SC; Erdos MR; Sanna S; Hottenga JJ; Wheeler E; Kaakinen M; Lyssenko V; Chen WM; Ahmadi K; Beckmann JS; Bergman RN; Bochud M; Bonnycastle LL; Buchanan TA; Cao A; Cervino A; Coin L; Collins FS; Crisponi L; de Geus EJ; Dehghan A; Deloukas P; Doney AS; Elliott P; Freimer N; Gateva V; Herder C; Hofman A; Hughes TE; Hunt S; Illig T; Inouye M; Isomaa B; Johnson T; Kong A; Krestyaninova M; Kuusisto J; Laakso M; Lim N; Lindblad U; Lindgren CM; McCann OT; Mohlke KL; Morris AD; Naitza S; Orrù M; Palmer CN; Pouta A; Randall J; Rathmann W; Saramies J; Scheet P; Scott LJ; Scuteri A; Sharp S; Sijbrands E; Smit JH; Song K; Steinthorsdottir V; Stringham HM; Tuomi T; Tuomilehto J; Uitterlinden AG; Voight BF; Waterworth D; Wichmann HE; Willemsen G; Witteman JC; Yuan X; Zhao JH; Zeggini E; Schlessinger D; Sandhu M; Boomsma DI; Uda M; Spector TD; Penninx BW; Altshuler D; Vollenweider P; Jarvelin MR; Lakatta E; Waeber G; Fox CS; Peltonen L; Groop LC; Mooser V; Cupples LA; Thorsteinsdottir U; Boehnke M; Barroso I; Van Duijn C; Dupuis J; Watanabe RM; Stefansson K; McCarthy MI; Wareham NJ; Meigs JB; Abecasis GR
Nat Genet; 2009 Jan; 41(1):77-81. PubMed ID: 19060907
[TBL] [Abstract][Full Text] [Related]
18. Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11).
Zusi C; Rinaldi E; Bonetti S; Boselli ML; Trabetti E; Malerba G; Bonora E; Bonadonna RC; Trombetta M
J Endocrinol Invest; 2021 Dec; 44(12):2567-2574. PubMed ID: 34128214
[TBL] [Abstract][Full Text] [Related]
19. Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk.
Rees MG; Wincovitch S; Schultz J; Waterstradt R; Beer NL; Baltrusch S; Collins FS; Gloyn AL
Diabetologia; 2012 Jan; 55(1):114-22. PubMed ID: 22038520
[TBL] [Abstract][Full Text] [Related]
20. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population.
Vaxillaire M; Cavalcanti-Proença C; Dechaume A; Tichet J; Marre M; Balkau B; Froguel P;
Diabetes; 2008 Aug; 57(8):2253-7. PubMed ID: 18556336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
